|Day Low/High||0.35 / 0.42|
|52 Wk Low/High||0.37 / 2.10|
Selexis SA and Pelican Therapeutics ("Pelican"), a subsidiary of Heat Biologics, Inc.
Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.
Rosen Law Firm announces that, following discussions with management and having gained a better understanding of the facts surrounding Heat Biologic's (NASDAQ:HTBX) recent bladder cancer trial for Vesigenurtacel-L (HS-410),...
Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Heat Biologics, Inc.
Remains on Track to Report Multiple Topline Data Readouts this Quarter
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.